Longitudinal Study of Symptoms in Colorectal Cancer
|ClinicalTrials.gov Identifier: NCT00777192|
Recruitment Status : Active, not recruiting
First Posted : October 22, 2008
Last Update Posted : February 23, 2017
|Condition or disease||Intervention/treatment|
|Colorectal Cancer||Behavioral: Questionnaires|
If you agree to take part in this study, you will complete 5 questionnaires during a regularly scheduled visit. The questionnaires are designed to measure pain and other symptoms, your mood, and your quality of life.
You will also give a tissue sample by inserting a cotton tipped swab into your mouth and rubbing firmly against the inside of your cheek or underneath your lower or upper lip for about 1 minute at the most.
Completing the 5 questionnaires and the swab sample should take about 30 minutes.
Length of Study:
After you complete the questionnaires and the swab sample collection, your active participation in this study will be over.
This is an investigational study.
Up to 500 patients will take part in this study. All will be enrolled at MD Anderson.
|Study Type :||Observational|
|Estimated Enrollment :||500 participants|
|Official Title:||Prospective Study of Symptoms Related to Oxaliplatin-based Regimens in the Treatment of Colorectal Cancer|
|Actual Study Start Date :||August 2008|
|Estimated Primary Completion Date :||August 2018|
|Estimated Study Completion Date :||August 2018|
Symptoms in Colorectal Cancer
Colorectal Cancer Patients Receiving Oxaliplatin Chemotherapy
20 Minute Questionnaires beginning Visit 1, to measure pain/other symptoms, mood, and quality of life
- Association between inflammatory cytokines and development of treatment-related symptom burden in colorectal cancer patients [ Time Frame: 5 Years ]
- Primary afferent function in colorectal cancer patients receiving chemotherapy by quantitative sensory testing over time [ Time Frame: 5 Years ]
- Neurocognitive and neuropsychiatric symptoms in colorectal cancer patients [ Time Frame: Neuropsychological test battery at baseline and 3 + 6 month follow ups ]
Biospecimen Retention: Samples With DNA
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00777192
|United States, Texas|
|University of Texas MD Anderson Cancer Center|
|Houston, Texas, United States, 77030|
|Principal Investigator:||Xin Shelley Wang, MD. MPH||M.D. Anderson Cancer Center|